American Journal of Clinical Oncology · 1998 · 117 citations · 16 references
MedicineOncologyPharmacologyCancer PharmacologyChemotherapyClinical PharmacologyChemotherapy Drug AdministrationChemotherapy Toxicity ManagementCombination ChemotherapyGastrointestinal Cancer PharmacotherapyOncology PharmacologyPharmacokinetics Of Anticancer DrugsChemotherapy Administration SafetyChemotherapy-induced Gastrointestinal ToxicityGastric Cancer PharmacotherapyPartial Response AssessmentPhase Ii Investigation
The purpose of this study was to evaluate the feasibility and efficacy of 3-hour infusional paclitaxel for the treatment of advanced gastric cancer with measurable metastatic diseases. Eligibility criteria included no more than one regimen of prior chemotherapy. Paclitaxel was administered as an intravenous infusion over 3 hours at a dose of 210 mg/m2 every 3 weeks. Premedication of dexamethazone, ranitidine, and diphenhydramine were given to all patients. Sixteen patients were registered in the study. One patient did not receive paclitaxel because of gastrointestinal bleeding before the initiation of drug's administration. Thirteen of the 15 patients had a prior history of chemotherapy. Although 10 patients (67%) developed grade 4 neutropenia, no serious infections occurred during the study. Nonhematologic toxicities were generally mild. Three (20%) patients who showed evidences of resistance to the previous intensive regimen achieved a partial response. In conclusion, a 3-hour infusion of paclitaxel is a safe and promising treatment for advanced gastric cancer. Paclitaxel appears to be non-cross resistant to other agents that are commonly used for gastric cancer. A large-scale phase II study is now underway.
16
D. W. Smithers · The Lancet · 1956 · 1.8K citations
Hypersensitivity reactions from taxol.
R B Weiss, Ross C. Donehower, Peter H. Wiernik et al. · Journal of Clinical Oncology · 1990 · 1.2K citations
Medicine, Oncology, Pharmacology +9
One-Sample Multiple Testing Procedure for Phase II Clinical Trials
Thomas R. Fleming · Biometrics · 1982 · 997 citations